首页> 外文会议>Computational Intelligence in Bioinformatics and Computational Biology, 2008 IEEE Symp on >Using hybrid GA-ANN to predict biological activity of HIV protease inhibitors
【24h】

Using hybrid GA-ANN to predict biological activity of HIV protease inhibitors

机译:使用混合GA-ANN预测HIV蛋白酶抑制剂的生物学活性

获取原文

摘要

The prediction of biological activity of a chemical compound from its structural features, representing its physico-chemical properties, plays an important role in drug discovery, design and development. Since the biological data is highly non-linear, the machine-learning techniques have been widely used for modeling it. In the present work, the clustering, genetic algorithm (GA) and artificial neural networks (ANN) are used to develop computational prediction models on a dataset of HIV protease inhibitors. The hybrid GA-ANN technique is used for feature selection. The ANN-QSAR prediction models are then developed to link the structures to their reported biological activity. These models can be useful for predicting the biological activity of new untested HIV protease inhibitors and virtual screening for identifying new lead compounds.
机译:从化合物的结构特征(代表其物理化学性质)预测化合物的生物活性,在药物发现,设计和开发中起着重要作用。由于生物学数据是高度非线性的,因此机器学习技术已被广泛用于对其建模。在目前的工作中,使用聚类,遗传算法(GA)和人工神经网络(ANN)在HIV蛋白酶抑制剂的数据集上开发计算预测模型。混合GA-ANN技术用于特征选择。然后开发ANN-QSAR预测模型,以将结构与其报道的生物活性联系起来。这些模型可用于预测新的未经测试的HIV蛋白酶抑制剂的生物学活性,以及​​用于筛选新的先导化合物的虚拟筛选。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号